TCTR20140908001Enrolling By InvitationPhase 1
Pharmacokinetics of Kratom in Man
Faculty of Medicine Ramathibodi Hospital, Mahidol University0 sites10 target enrollmentStarted: September 8, 2014Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Enrolling By Invitation
- Enrollment
- 10
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20 Years to 60 Years (—)
- Sex
- All
Inclusion Criteria
- •The participants who had no underlying diseases, use Kratom regularly more than 6 months, had the positive urine or blood for mitragynine at the 1st hospital visit.
Exclusion Criteria
- •The participants denied to participate in the study
Investigators
Similar Trials
Completed
Phase 1
Pharmacokinetic study and effects of kratom (Mitragyna speciosa Korth.) on electroencephalogram in healthy volunteersTCTR20140729001ational Science and Technology Development Agency18
Recruiting
Not Applicable
Study on Pharmacokinetics and Pharmacodynamics of high dose Daptomycin.Infectious DiseaseJPRN-UMIN000017226Keio University20
Recruiting
Not Applicable
Study on Pharmacokinetics and Pharmacodynamics of high dose Meropenem.infectious diseaseJPRN-UMIN000017225Keio University20
Withdrawn
Not Applicable
A Phase 1 Pharmacokinetic-Pharmacodynamic Study of Avelumab (MSB00100718C) in Patients with Previously Treated Advanced Stage Classical Hodgkin*s LymphomaHodgkin's Lymphomalymph node cancer10025319NL-OMON43446Pfizer15
Active, not recruiting
Phase 1
Pharmacokinetic and pharmacodynamic evaluation of linezolid administered intravenously in MRSA-positive, morbidly obese patients with pneumonia.EUCTR2012-005127-33-BEniversity Ghent20